Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 3/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 1/20 | 0.37 |
| ▸ | BTK | Q06187 | 1/20 | 0.37 |
| ▸ | CCNT1 | O60563 | 6/20 | 0.36 |
| ▸ | CDK9 | P50750 | 6/20 | 0.36 |
| ▸ | KHK | P50053 | 1/20 | 0.35 |
| ▸ | KIT | P10721 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20760446 | 0.85 | HTR2C (0.39) | HTR2CHTR2AHTR7HTR6ALOX5AP | |
| SCHEMBL15001472 | 0.76 | HRH3 (0.46) | HTR2CHTR2AHTR7HTR6CCNT1 | |
| SCHEMBL28439457 | 0.75 | HTR6 (0.39) | HTR2CHTR2AHTR7HTR6CCNT1 | |
| SCHEMBL20759670 | 0.75 | HTR6 (0.39) | HTR2CHTR2AHTR7HTR6CCNT1 | |
| Hydrochloric Acid SCHEMBL28448600 | 0.75 | HTR2C (0.38) | HTR2CHTR2AHTR7HTR6ALOX5AP | |
| Hydrochloric Acid SCHEMBL28448601 | 0.75 | HTR2C (0.38) | HTR2CHTR2AHTR7HTR6ALOX5AP | |
| SCHEMBL20759680 | 0.73 | BTK (0.36) | HTR2CHTR2AHTR7HTR6ALOX5AP | |
| SCHEMBL20759806 | 0.73 | HTR2C (0.40) | HTR2CHTR6ALOX5APFEN1CCNT1 | |
| SCHEMBL20760623 | 0.73 | NPC1 (0.44) | HTR2CHTR2AHTR7HTR6CCNT1 | |
| SCHEMBL20759601 | 0.72 | SIGMAR1 (0.49) | HTR2CHTR2AHTR7HTR6CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022081627-A1 | COMPOSITIONS AND METHODS FOR TREATING KIT-AND PDGFRA-MEDIATED DISEASES | BLUEPRINT MEDICINES CORPORATION (US) | 2022-04-21 | — | — | WO | disclosed |